Jiangxi Fushine Pharmaceutical Co Ltd (300497) — Financial Flexibility Index
Jiangxi Fushine Pharmaceutical Co Ltd (300497) has a Financial Flexibility Index of 0.03x as of September 2025. Free cash flow of CN¥61.36 Million (operating CF CN¥18.31 Million minus capex CN¥43.04 Million) represents 0% of total liabilities (CN¥2.27 Billion). Also explore Jiangxi Fushine Pharmaceutical Co Ltd net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Jiangxi Fushine Pharmaceutical Co Ltd Financial Flexibility Index (2011–2025)
Historical Financial Flexibility Index trend for Jiangxi Fushine Pharmaceutical Co Ltd across 15 annual periods. Check Jiangxi Fushine Pharmaceutical Co Ltd strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Jiangxi Fushine Pharmaceutical Co Ltd (2011–2025)
Year-by-year free cash flow to debt coverage for Jiangxi Fushine Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see Jiangxi Fushine Pharmaceutical Co Ltd stock valuation.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.13x | CN¥287.56 Million | CN¥62.67 Million | CN¥2.20 Billion | ▼ -6.5% |
| 2024 | 0.14x | CN¥329.39 Million | CN¥187.64 Million | CN¥2.36 Billion | ▲ +84.7% |
| 2023 | 0.08x | CN¥177.46 Million | CN¥-64.76 Million | CN¥2.35 Billion | ▼ -47.1% |
| 2022 | 0.14x | CN¥338.56 Million | CN¥-120.85 Million | CN¥2.37 Billion | ▼ -66.4% |
| 2021 | 0.43x | CN¥751.92 Million | CN¥72.32 Million | CN¥1.77 Billion | ▼ -48.9% |
| 2020 | 0.83x | CN¥831.59 Million | CN¥382.35 Million | CN¥997.93 Million | ▲ +34.3% |
| 2019 | 0.62x | CN¥662.81 Million | CN¥337.91 Million | CN¥1.07 Billion | ▲ +91.7% |
| 2018 | 0.32x | CN¥339.80 Million | CN¥175.91 Million | CN¥1.05 Billion | ▼ -14.0% |
| 2017 | 0.38x | CN¥309.72 Million | CN¥210.72 Million | CN¥822.70 Million | ▼ -14.3% |
| 2016 | 0.44x | CN¥269.87 Million | CN¥188.53 Million | CN¥614.20 Million | ▲ +22.9% |
| 2015 | 0.36x | CN¥147.75 Million | CN¥74.01 Million | CN¥413.44 Million | ▲ +49.9% |
| 2014 | 0.24x | CN¥83.25 Million | CN¥31.39 Million | CN¥349.09 Million | ▼ -44.1% |
| 2013 | 0.43x | CN¥132.82 Million | CN¥57.22 Million | CN¥311.55 Million | ▲ +8.7% |
| 2012 | 0.39x | CN¥114.44 Million | CN¥63.20 Million | CN¥291.70 Million | ▼ -21.5% |
| 2011 | 0.50x | CN¥116.01 Million | CN¥33.80 Million | CN¥232.04 Million | — |